Skip to main content

Advertisement

Log in

Do blood groups have effect on prognosis of patients undergoing radical cystectomy?

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of the study was to investigate the effect of ABO blood groups and Rhesus (Rh) factor on prognosis of patients undergoing radical cystectomy.

Materials and methods

In this study, total number of 290 patients who underwent radical cystectomy between January 1990 and September 2012 were evaluated retrospectively. Patients were grouped as O and non-O according to ABO antigens; also positive and negative according to Rh factor. Parameters such as age, sex, stage, lymph node involvement and positive surgical margins were investigated. Disease-free and overall survival rates have been compared. Multivariate analysis were performed to determine independent prognostic factors.

Results

A total of 260 (89.7 %) male and 30 (10.3 %) female patients participated in the study. Mean follow-up was 37.7 ± 18.9 months. A total of 180 patients were non-O (62.1 %),while the 110 patients had the blood group O (37.9 %). The number of Rh positive and negative patients were 247 (85.2 %) and 43 (14.8 %), respectively. According to the univariate and multivariate analyses, ABO blood groups and Rh factor did not exhibit any significant impact on overall and disease-specific survival.

Conclusion

ABO blood group and Rh factor were not associated with the prognosis of bladder cancer patients who underwent radical cystectomy. However, prospective studies are needed in larger patient series for further evaluations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics. CA Cancer J Clin 2009(59):225–249

    Article  Google Scholar 

  2. Hautmann RE, Abol-Enein H, Hafez K, Haro I, Mansson W, Mills RD et al (2007) World Health Organization (WHO) Consensus Conference in Bladder Cancer. Urin divers Urol 69(1 Suppl):17–49

    Google Scholar 

  3. Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS et al (2011) Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines; European Association of Urology (EAU). Eur Urol 59(6):1009–1018

    Article  CAS  PubMed  Google Scholar 

  4. Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A et al (2008) Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 180:121–127

    Article  PubMed  Google Scholar 

  5. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176(6):2414–2422

    Article  PubMed  Google Scholar 

  6. Madersbacher S, Hochreiter W, Burkhard F, Thalmann GN, Danuser H, Markwalder R et al (2003) Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy. J Clin Oncol 21(4):690–696

    Article  PubMed  Google Scholar 

  7. Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M et al (2008) The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis. BJU Int 102(8):952–957

    Article  PubMed  Google Scholar 

  8. Sánchez-Ortiz RF, Huang WC, Mick R, Van Arsdalen KN, Wein AJ et al (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169(1):110–115

    Article  PubMed  Google Scholar 

  9. Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G et al (2005) Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 104(1):36–43

    Article  PubMed  Google Scholar 

  10. Thalmann GN, Stein JP (2008) Outcomes of radical cystectomy. BJU Int 102(9 Pt B):1279–1288

    Article  PubMed  Google Scholar 

  11. Landsteiner K (1900) Zur Kenntnis der antifermentativen, lytischen and agglutinierenden Wirkungen des Blutserums und der Lymphe. Zentralbl Bakteriol 27:357–362

    Google Scholar 

  12. Graziano SL, Tatum AH, Gonchoroff NJ (1997) Blood group antigen A and flow cytometric analysis in resected early stage non-small cell lung cancer. Clin Cancer Res 3:87–93

    CAS  PubMed  Google Scholar 

  13. Zmijewski CM (1978) Immunohematology, 3rd edn. Appleton Century Crofts, New York

    Google Scholar 

  14. Aird I, Bentall HH, Roberts JA (1953) A relationship between cancer of stomach and the ABO blood groups. Br Med J 1:799–801

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ et al (2009) ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 101:424–431

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Moldvay J, Scheid P, Wild P, Nabil K, Siat J, Borrelly J et al (2000) Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 6:1125–1134

    CAS  PubMed  Google Scholar 

  17. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M et al (2010) Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 172:1280–1285

    Article  PubMed  Google Scholar 

  18. Wolpin BM, Kraft P, Gross M, Helzlsouer K, Bueno-de-Mesquita HB, Steplowski E et al (2010) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 70:1015–1023

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Malmström PU, Busch C, Norlen BJ, Andersson B (1988) Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma. Scand J Urol Nephrol 22:265–270

    Article  PubMed  Google Scholar 

  20. Summers JL, Coon JS, Ward RM, Falor WH, Miller AW III, Weinstein RS (1983) Prognosis in carcinoma of the urinary bladder upon tissue blood group ABH and Thompsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res 43:93–99

    Google Scholar 

  21. Costantini M, Fassio T, Canobbio L, Landucci M, Resasco M, Boccardo F (1990) Role of blood groups as prognostic factors in primary breast cancer. Oncology 47:308–312

    Article  CAS  PubMed  Google Scholar 

  22. Rahbari NN, Bork U, Hinz U et al (2012) AB0 blood group and prognosis in patients with pancreatic cancer. BMC Cancer 28(12):319–328

    Article  Google Scholar 

  23. Torun YA, Kaynar LG, Karakükcü Ç, Yay M, Kurnaz F, Mutlu H, Çetin M, Eser B (2012) Turk J Haematol 29:97–98

    PubMed Central  PubMed  Google Scholar 

  24. Reid ME, Mohandas N (2004) Red blood cellblood group antigens: structure and function. Semin Hematol 41:93–117

    Article  CAS  PubMed  Google Scholar 

  25. Dall’olio F (1996) Protein glycosylation in cancer biology: an overview. Clin Mol Pathol 49:126–135

    Article  Google Scholar 

  26. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clément M (2001) ABH and Lewis histo-blood group antigens in cancer. APMIS 109:9–31

    Article  PubMed  Google Scholar 

  27. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB (2010) ABO blood group andcancer. Eur J Cancer 46:3345–3350

    Article  CAS  PubMed  Google Scholar 

  28. Kaffenberger SD, Morgan TM, Stratton KL, Boachie AM, Barocas DA, Chang SS et al (2012) ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int 110(11 Pt B):E641–E646

    Article  PubMed  Google Scholar 

  29. Catalona WJ (1981) Practical utility of specific red cell adherence test in bladder cancer. Urology 18:113–117

    Article  CAS  PubMed  Google Scholar 

  30. Klatte T, Xylinas E, Rieken M, Kluth LA, Rouprêt M, Pycha A et al (2013) Impact of ABO blood type on outcomes of patients with primary non-muscle-invasive bladder cancer. J Urol. doi:10.1016/j.juro.2013.11.106

    Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Evren Süer.

Additional information

Recently, Klatte et al. [30] demonstrated O blood group as an independent predictor for reccurence and progression in NMIBC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Süer, E., Özcan, C., Gökçe, İ. et al. Do blood groups have effect on prognosis of patients undergoing radical cystectomy?. Int Urol Nephrol 46, 1521–1526 (2014). https://doi.org/10.1007/s11255-014-0698-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-014-0698-x

Keywords

Navigation